Trius Therapeutics Inc — Form D

Trius Therapeutics Inc of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-12. The offering totals $30.0M, of which $19.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Karin G EasthamDirectorSan Diego, CA
David KabakoffDirectorBrisbane, CA
Nina G KjellsonDirectorSan Diego, CA
Michael G PowellDirectorSan Francisco, CA
Risa StackDirectorBerkeley, CA
Paul TruexDirectorSanta Clara, CA
Kenneth G BartizalExecutive OfficerSan Diego, CA
Philippe G ProkocimerExecutive OfficerSan Diego, CA
John SchmidExecutive OfficerSan Diego, CA
Jeffrey SteinDirectorSan Francisco, CA
Jeffrey SteinExecutive OfficerSan Francisco, CA
Theodore R SchroederDirectorSan Diego, CA
John FinnExecutive OfficerLouisville, CO
Brian G AtwoodDirectorGaithersburg, MD
Nina S KjellsonDirectorPalo Alto, CA
Paul F TruexDirectorMilpitas, CA
Risa P StackDirectorSouth San Francisco, CA
Michael S PowellDirectorSan Francisco, CA
Karin S EasthamDirectorSan Diego, CA
Philippe S ProkocimerExecutive OfficerSan Diego, CA
Kenneth S BartizalExecutive OfficerSan Diego, CA
John P SchmidExecutive OfficerSan Diego, CA
Brenden R O'LearyDirectorNeedham, MA
David S KabakoffDirectorSan Diego, CA
Michael R MorneauExecutive OfficerSan Diego, CA

Other filings by this issuer (1)

FiledFormOfferingSold
2011-06-07D$44.3M$30.2M

More